Niresh Hariparsad

11PUBLICATIONS
85CO-AUTHORS
Haematological tumoursPharmacogenomicsPharmaceutical delivery technologiesMolecular targetsPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 29, 2026
AZ'4331 is a novel pan-TEAD auto-palmitoylation inhibitor for the treatment of Hippo pathway-altered cancers.

|Nov 06, 2025
A mismatch in enzyme-redox partnerships underlies divergent cytochrome P450 activities between human hepatocytes and microsomes.

Tashinga E Bapiro, Scott Martin, Thomas S Blacker

|Jul 14, 2025
Advancing Predictions of Oral Drug Absorption, CYP3A4 Induction, and Transporter-Mediated Interactions Using a Human Primary Intestinal 3D Model (EpiIntestinal™).

Paresh P Chothe, Andrea Whitcher-Johnstone, Aniruddha Karve

|Jun 16, 2025
Synthetic chemistry enabling the discovery and development of a series of pyrazoles as HPK1 inhibitors.

Anthony J Metrano, Lucas A Morrill, Gayathri Bommakanti

|Feb 10, 2025
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor.

Jason D Shields, David Baker, Amber Y S Balazs

|Jan 02, 2025
Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease.

Brandon Zimmerman, Leslie A Dakin, Anne Fortier

Pageof 2

Frequent Collaborators

4 joint publications

Diane Ramsden

3 joint publications

Neil P Grimster

3 joint publications

Marianne Schimpl

2 joint publications

Adelphe M Mfuh